Resultados da busca - Henrik Roed

  • Mostrando 1 - 4 resultados de 4
Refinar Resultados
  1. 1
    Prospective study on stereotactic radiotherapy of limited-stage non–small-cell lung cancer

    Prospective study on stereotactic radiotherapy of limited-stage non–small-cell lung cancer por Morten Høyer, Henrik Roed, Anders T. Hansen, Lars Ohlhuis, J. Petersen, Hanne Marie Nellemann, Anne Kiil Berthelsen, Cai Grau, Svend Aage Engelholm, Hans von der Maase

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  2. 2
    Phase II study on stereotactic body radiotherapy of colorectal metastases

    Phase II study on stereotactic body radiotherapy of colorectal metastases por Morten Høyer, Henrik Roed, Anders T. Hansen, Lars Ohlhuis, J. Petersen, Hanne Marie Nellemann, Anne Kiil Berthelsen, Cai Grau, Svend Aage Engelholm, Hans von der Maase

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

    Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial por Mansoor Raza Mirza, Elisabeth Åvall Lundqvist, Michael J. Birrer, René dePont Christensen, Gitte-Bettina Nyvang, Susanne Malander, Maarit Anttila, Theresa L. Werner, Bente Lund, Gabriel Lindahl, Sakari Hietanen, Ulla Peen, Maria Dimoula, Henrik Roed, Anja Ør Knudsen, Synnöve Staff, Anders Krog Vistisen, Line Bjørge, Johanna Mäenpää

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    LBA28 A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial

    LBA28 A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recur... por Mansoor Raza Mirza, Line Bjørge, Frederik Marmé, René dePont Christensen, Marta Gil-Martín, Annika Auranen, Beyhan Ataseven, María Jesús Rubio, Vanda Salutari, Bente Lund, IB Runnebaum, Andrés Redondo, Kristina Lindemann, Fabian Trillsch, M.P. Barretina Ginesta, Henrik Roed, Joan Løhndorf, G-B. Nyvang, Jalid Sehouli

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: